OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differences in epithelial-mesenchymal-transition in paraquat-induced pulmonary fibrosis in BALB/C and BALB/C (nu/nu) nude mice
Yegang Hu, Chuanyun Qian, Huiling Sun, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112153-112153
Open Access | Times Cited: 10

Showing 10 citing articles:

E2F1 regulates miR-215-5p to aggravate paraquat-induced pulmonary fibrosis via repressing BMPR2 expression
Jie Huang, Yan Cao, Xiang Li, et al.
Toxicology Research (2022) Vol. 11, Iss. 6, pp. 940-950
Open Access | Times Cited: 14

Barbaloin attenuates pulmonary fibrosis through TGF-β1/Smads/p38 pathway
Gong Zhang, Rong Bai, Jianlin Huang, et al.
Journal of Pharmacy and Pharmacology (2022) Vol. 74, Iss. 8, pp. 1160-1169
Closed Access | Times Cited: 10

Voluntary wheel-running improved pulmonary fibrosis by reducing epithelial mesenchymal transformation
Yan Gao, Zhaoyun Yang, Kang He, et al.
Life Sciences (2023) Vol. 331, pp. 122066-122066
Closed Access | Times Cited: 4

Mesenchymal stem cell-based therapy for paraquat-induced lung injury
Xiaping Zhang, Ting Li, Yuan‐Qiang Lu
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 1

Pathophysiological Changes in Rhesus Monkeys with Paraquat-Induced Pulmonary Fibrosis
Mingyang Shao, Sha Yang, Aiyi Zheng, et al.
Lung (2022) Vol. 200, Iss. 5, pp. 549-560
Open Access | Times Cited: 6

The novel peptide DR4penA attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the TGFβ/Smad signaling pathway
Dan Wang, Bochuan Deng, Lu Cheng, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 2

The peptide DR3penA exhibits antifibrotic activity in multiple pulmonary fibrosis models induced by particulate and soluble chemical fibrogenic agents
Jieru Li, Bochuan Deng, Jiao Zhang, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 701-714
Open Access | Times Cited: 2

Amphibian-derived peptide RL-RF10 ameliorates paraquat-induced pulmonary fibrosis injury
Huiling Sun, Yutong Wu, Ziqian Xiong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116184-116184
Open Access

Page 1

Scroll to top